Tom Gallen

Tom Gallen

Managing Editor, Europe

Birmingham, UK

Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest from Tom Gallen

Lupin Goes For Growth With Indian Consumer Health Spin-Off

With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.

AstaReal Launches Membralife Supplement Following CEO Change

Designed to help moisturize the body’s mucous membranes, the Membralife supplement is now available in Sweden. The launch comes with AstaReal now under new management following the appointment of Daniel Flodqvist as CEO.

Haleon Takes Full Control Of China JV

Haleon finalizes deal to make its China joint venture a wholly-owned subsidiary in move to "drive category growth in one of the fastest growing OTC markets globally."

People On The Move: Appointments At Kenvue, EFSA, FSE

A round-up of the latest people moves: Kenvue names APAC president; EFSA nominates executive director; Food Supplements Europe elects board.

Opella Claims Sustainability Leadership Position With Global B Corp Certification

Cutting greenhouse gas emissions and obtaining its electricity from renewable sources has helped Opella earn global B Corp certification.

Danone Acquires Belgian Firm Marketing Gut Health Supplement in US

Danone moves into dietary supplements space with deal for The Akkermansia Company marketing patented biotic strain in US, Europe and Asia.